Renal safety and biochemical changes for 2 years after switching to tenofovir alafenamide from long‐term other nucleotide analog treatment in patients with chronic hepatitis B-Reference-Cited by-同舟云学术

Renal safety and biochemical changes for 2 years after switching to tenofovir alafenamide from long‐term other nucleotide analog treatment in patients with chronic hepatitis B

Published:2021-11-06 Issue:2 Volume:52 Page:153-164
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Hosaka Tetsuya¹^ORCID,Suzuki Fumitaka¹,Kobayashi Masahiro¹,Fujiyama Shunichirou¹^ORCID,Kawamura Yusuke¹^ORCID,Sezaki Hitomi¹^ORCID,Akuta Norio¹^ORCID,Suzuki Yoshiyuki¹,Saitoh Satoshi¹,Arase Yasuji¹,Ikeda Kenji¹,Kobayashi Mariko²,Kumada Hiromitsu¹

Affiliation:

1. Department of Hepatology Toranomon Hospital Tokyo Japan

2. Research Institute for Hepatology Toranomon Hospital Tokyo Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13726

Reference27 articles.

1. Randomized prospective study showing the non-inferiority of tenofovir to entecavir in treatment-naïve chronic hepatitis B patients

2. Efficacy and safety of tenofovir disoproxil fumarate rescue therapy for chronic hepatitis B patients who failed other nucleos(t)ide analogs

3. Advancing Age and Comorbidity in a US Insured Population-Based Cohort of Patients With Chronic Hepatitis B

4. An Aging Population of Chronic Hepatitis B With Increasing Comorbidities: A Territory‐Wide Study From 2000 to 2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comments on: Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis;Hepatology International;2024-03-02

2. Application of Tenofovir Alafenamide Fumarate in Patients with Chronic Hepatitis B;Advances in Clinical Medicine;2024

3. Effects of entecavir and tenofovir alafenamide fumarate treatment on renal function in Japanese elderly patients with chronic hepatitis B;Hepatology Research;2023-11-08

4. Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis;Hepatology International;2023-04-26